Kotlyar J, Granstein R
Brain Behav Immun Health. 2025; 44:100958.
PMID: 40008232
PMC: 11851231.
DOI: 10.1016/j.bbih.2025.100958.
Sandu R, Singh J
Inflammopharmacology. 2025; .
PMID: 39934537
DOI: 10.1007/s10787-025-01657-6.
Tokuyasu D, Imai S, Chen S, Chen S, Ihara K, Watanabe N
BMC Neurol. 2025; 25(1):1.
PMID: 39748278
PMC: 11694463.
DOI: 10.1186/s12883-024-04009-z.
Azadi S, Yazdanpanah M, Afshari A, Alahdad N, Chegeni S, Angaji A
J Tissue Eng. 2024; 15:20417314241303818.
PMID: 39670180
PMC: 11635874.
DOI: 10.1177/20417314241303818.
Barbosa Bomfim C, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, Murigneux E, Sams A
J Virol. 2024; 98(9):e0012824.
PMID: 39162434
PMC: 11406896.
DOI: 10.1128/jvi.00128-24.
Unravelling the role of beta-CGRP in inflammatory bowel disease and its potential role in gastrointestinal homeostasis.
Pascual-Mato M, Garate G, Gonzalez-Quintanilla V, Castro B, Garcia M, Crespo J
BMC Gastroenterol. 2024; 24(1):262.
PMID: 39134940
PMC: 11320777.
DOI: 10.1186/s12876-024-03366-w.
Lack of alpha CGRP exacerbates the development of atherosclerosis in ApoE-knockout mice.
Hashikawa-Hobara N, Inoue S, Hashikawa N
Sci Rep. 2024; 14(1):18377.
PMID: 39112593
PMC: 11306347.
DOI: 10.1038/s41598-024-69331-5.
CGRP promotes osteogenic differentiation by regulating macrophage M2 polarization through HDAC6/AKAP12 signaling pathway.
Chen W, Ma L, Sun W, Xiao W, Guo H, Xiu J
Regen Med. 2024; 19(7-8):379-391.
PMID: 39072399
PMC: 11370908.
DOI: 10.1080/17460751.2024.2370697.
Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study.
Krajnc N, Frank F, Macher S, Michl M, Muller N, Maier S
J Headache Pain. 2024; 25(1):92.
PMID: 38834953
PMC: 11149324.
DOI: 10.1186/s10194-024-01799-y.
CGRP as a potential mediator for the sexually dimorphic responses to traumatic brain injury.
Li C, Ajmal E, Alok K, Powell K, Wadolowski S, Tambo W
Biol Sex Differ. 2024; 15(1):44.
PMID: 38816868
PMC: 11138127.
DOI: 10.1186/s13293-024-00619-x.
Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience.
Garate G, Pascual J, Pascual-Mato M, Madera J, Munoz-San Martin M, Gonzalez-Quintanilla V
J Headache Pain. 2024; 25(1):69.
PMID: 38684990
PMC: 11057141.
DOI: 10.1186/s10194-024-01769-4.
Expression of Calcitonin Gene-Related Peptide and Calcitonin Receptor-like Receptor in Colorectal Adenocarcinoma.
Serban R, Stepan M, Florescu D, Boldeanu M, Florescu M, Serbanescu M
Int J Mol Sci. 2024; 25(8).
PMID: 38674047
PMC: 11050384.
DOI: 10.3390/ijms25084461.
Functional Analysis and Tissue-Specific Expression of Calcitonin and CGRP with RAMP-Modulated Receptors CTR and CLR in Chickens.
Huang T, Su J, Wang X, Shi N, Zhang X, He J
Animals (Basel). 2024; 14(7).
PMID: 38612299
PMC: 11010885.
DOI: 10.3390/ani14071058.
RNA-binding proteins in pain.
Smith P, Campbell Z
Wiley Interdiscip Rev RNA. 2024; 15(2):e1843.
PMID: 38576117
PMC: 11003723.
DOI: 10.1002/wrna.1843.
Sensory nerve and neuropeptide diversity in adipose tissues.
Mishra G, Townsend K
Mol Cells. 2024; 47(2):100030.
PMID: 38364960
PMC: 10960112.
DOI: 10.1016/j.mocell.2024.100030.
Ubrogepant: Mechanism of action, clinical and translational science.
Boinpally R, Shebley M, Trugman J
Clin Transl Sci. 2024; 17(1):e13675.
PMID: 38266060
PMC: 10777434.
DOI: 10.1111/cts.13675.
Syntaxin1A overexpression and pain insensitivity in individuals with 7q11.23 duplication syndrome.
Iadarola M, Sapio M, Loydpierson A, Mervis C, Fehrenbacher J, Vasko M
JCI Insight. 2024; 9(4).
PMID: 38261410
PMC: 10967379.
DOI: 10.1172/jci.insight.176147.
Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE).
Alsaadi T, Kayed D, Al-Madani A, Hassan A, Krieger D, Riachi N
Neurol Ther. 2024; 13(2):257-281.
PMID: 38240944
PMC: 10951165.
DOI: 10.1007/s40120-023-00576-4.
Pain persists in mice lacking both Substance P and CGRPα signaling.
MacDonald D, Jayabalan M, Seaman J, Balaji R, Nickolls A, Chesler A
bioRxiv. 2023; .
PMID: 38076807
PMC: 10705526.
DOI: 10.1101/2023.11.15.567208.
Mode and site of action of therapies targeting CGRP signaling.
Labastida-Ramirez A, Caronna E, Gollion C, Stanyer E, Dapkute A, Braniste D
J Headache Pain. 2023; 24(1):125.
PMID: 37691118
PMC: 10494408.
DOI: 10.1186/s10194-023-01644-8.